COMBI-d study
Read more about the COMBI-d study, such as the study design and the most important results.
Study design 1The patient population consisted of 423 patients with unresectable (Stage IIIC) or metastatic (...
Twitter Linkedin Facebook Pinterest Google plusPatient resources
220 study
Read more about the 220 study, such as the study design and the most important results.
Study design 1The patient population consisted of 162 patients with BRAF and/or Mek treatment-naïve melanoma in a...
Twitter Linkedin Facebook Pinterest Google plusCOMBI-v study
Read more about the COMBI-v study, such as the study design and the most important results.
Study design 1The patient population consisted of 704 patients with unresectable (Stage IIIC) or metastatic (...
Twitter Linkedin Facebook Pinterest Google plusPooled analysis from COMBI-v and COMBI-d
Read more about the COMBI-v and COMBI-d study, such as the study design and the most important results.
Pooled analysis 1An analysis has been done on pooled extended-survival data from two phase III...
Twitter Linkedin Facebook Pinterest Google plusSafety profile
Mechanism of Action
ESH Berlin 2023 Highlights
Xolair®: Refund first claim (A) (French)
Download French document To receive by post, click on the "Add to card" button below
